Literature DB >> 8331301

Rabbits immunized with a peptide encoded for by the 230-kD bullous pemphigoid antigen cDNA develop an enhanced inflammatory response to UVB irradiation: a potential animal model for bullous pemphigoid.

R P Hall1, J C Murray, M M McCord, M J Rico, R D Streilein.   

Abstract

Previous attempts to develop an animal model of bullous pemphigoid (BP) have failed to result in inflammatory disease in the skin. P1-2 is an 18-amino acid peptide encoded for by the 230-kD BP antigen cDNA that has been shown to contain an epitope recognized by circulating antibodies from patients with BP. The purpose of this study was to determine if ultraviolet B irradiation of rabbits after immunization with the P1-2 peptide would result in an enhanced inflammatory response in the skin to that injury. Three rabbits were immunized with either P1-2 or a control peptide. All rabbits immunized with P1-2, and none of the control rabbits, developed antibodies against P1-2 that bound in vitro to both human and rabbit skin in a linear pattern at the basement membrane zone. Immunized rabbits were irradiated on the flank with ultraviolet light. Rabbits immunized with P1-2 developed an enhanced inflammatory reaction to ultraviolet B irradiation leading to epidermal necrosis and sloughing of some sites in 6-9 d. Control rabbits showed only mild erythema without sloughing, which healed in 4-6 d. Histology in the P1-2 immunized rabbits at 24 h revealed an inflammatory infiltrate of neutrophils at the dermal-epidermal junction, whereas control rabbits showed only mild edema and a sparse inflammatory infiltrate. All the rabbits immunized with P1-2 had linear deposits of immunoglobulin G and C3 at the basement membrane zone of healed skin compared to none of the controls. These findings demonstrate that antibodies against a synthetic peptide encoded by the BP antigen 1 sequence can lead to an enhanced inflammatory response after epithelial injury in rabbit skin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8331301     DOI: 10.1111/1523-1747.ep12358276

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  13 in total

Review 1.  Plakins, a versatile family of cytolinkers: roles in skin integrity and in human diseases.

Authors:  Jamal-Eddine Bouameur; Bertrand Favre; Luca Borradori
Journal:  J Invest Dermatol       Date:  2013-12-19       Impact factor: 8.551

Review 2.  Bullous pemphigoid: An immune disorder related to aging (Review).

Authors:  Maria Ludovica Deotto; Alice Spiller; Alvise Sernicola; Mauro Alaibac
Journal:  Exp Ther Med       Date:  2021-11-15       Impact factor: 2.447

3.  Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice.

Authors:  M Amagai; T Nishikawa; H C Nousari; G J Anhalt; T Hashimoto
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

4.  IgE antibodies in sera from patients with bullous pemphigoid are autoantibodies preferentially directed against the 230-kDa epidermal antigen (BP230)

Authors:  R F Ghohestani; E Cozzani; E Delaporte; J F Nicolas; A Parodi; A Claudy
Journal:  J Clin Immunol       Date:  1998-05       Impact factor: 8.317

5.  Bullous pemphigoid IgG induces BP180 internalization via a macropinocytic pathway.

Authors:  Sho Hiroyasu; Toshiyuki Ozawa; Hiromi Kobayashi; Masamitsu Ishii; Yumi Aoyama; Yasuo Kitajima; Takashi Hashimoto; Jonathan C R Jones; Daisuke Tsuruta
Journal:  Am J Pathol       Date:  2013-01-19       Impact factor: 4.307

Review 6.  The pathophysiology of bullous pemphigoid.

Authors:  Michael Kasperkiewicz; Detlef Zillikens
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

7.  Missing the target: characterization of bullous pemphigoid patients who are negative using the BP180 enzyme-linked immunosorbant assay.

Authors:  Janet A Fairley; Matthew Bream; Colleen Fullenkamp; Sergei Syrbu; Mei Chen; Kelly N Messingham
Journal:  J Am Acad Dermatol       Date:  2012-10-18       Impact factor: 11.527

8.  Usefulness of Enzyme-linked Immunosorbent Assay Using Recombinant BP180 and BP230 for Serodiagnosis and Monitoring Disease Activity of Bullous Pemphigoid.

Authors:  Eui Hyung Lee; Yeon Hee Kim; Sinyoung Kim; Song-Ee Kim; Soo-Chan Kim
Journal:  Ann Dermatol       Date:  2012-02-02       Impact factor: 1.444

9.  The flavonoid luteolin inhibits Fcγ-dependent respiratory burst in granulocytes, but not skin blistering in a new model of pemphigoid in adult mice.

Authors:  Eva Oswald; Alina Sesarman; Claus-Werner Franzke; Ute Wölfle; Leena Bruckner-Tuderman; Thilo Jakob; Stefan F Martin; Cassian Sitaru
Journal:  PLoS One       Date:  2012-02-06       Impact factor: 3.240

10.  New onset bullous pemphigoid arising in Mohs surgical site.

Authors:  Matthew R Donaldson; L Arthur Weber; Caroline W Laggis
Journal:  JAAD Case Rep       Date:  2021-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.